APO RESEARCH · REPORT
Vinpocetine
Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
Product & engineering
Understand the product.
Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).
Selected research
Industry Research
Vinpocetine Industry Research Report 2026
Market perspective
Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).
In the US market, the major manufacturers are Gedeon Richter, Runhong, Sun Pharma, WZT, Pude, Welman and Zhitong.
Read the full market overview
Report Scope
This report quantifies the global Vinpocetine market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Vinpocetine Market by Company
Gedeon Richter
Runhong
Sun Pharma
WZT
PUDE
Welman
ZhiTong
Liaoning Zhiying
COVEX
Northeast Pharma
Micro Labs
Vinpocetine Segment by Type
Tablet
Injection
Vinpocetine Segment by Application
Household
Hospital
Vinpocetine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vinpocetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vinpocetine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vinpocetine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vinpocetine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vinpocetine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vinpocetine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Injection
Applications
- Household
- Hospital
Companies covered
- Gedeon Richter
- Runhong
- Sun Pharma
- WZT
- PUDE
- Welman
- ZhiTong
- Liaoning Zhiying
- COVEX
- Northeast Pharma
- Micro Labs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Vinpocetine Market Size (2021-2032)
- 2.2.2 Global Vinpocetine Sales (2021-2032)
- 2.2.3 Global Vinpocetine Market Average Price (2021-2032)
- 2.3 Vinpocetine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Injection
- 2.4 Vinpocetine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Household
- 2.4.3 Hospital
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Vinpocetine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Vinpocetine Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Vinpocetine Revenue of Manufacturers (2021-2026)
- 3.4 Global Vinpocetine Average Price by Manufacturers (2021-2026)
- 3.5 Global Vinpocetine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Vinpocetine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Vinpocetine, Product Type & Application
- 3.8 Global Manufacturers of Vinpocetine, Established Date
- 3.9 Global Vinpocetine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Gedeon Richter
- 4.1.1 Gedeon Richter Company Information
- 4.1.2 Gedeon Richter Business Overview
- 4.1.3 Gedeon Richter Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Gedeon Richter Vinpocetine Product Portfolio
- 4.1.5 Gedeon Richter Recent Developments
- 4.2 Runhong
- 4.2.1 Runhong Company Information
- 4.2.2 Runhong Business Overview
- 4.2.3 Runhong Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Runhong Vinpocetine Product Portfolio
- 4.2.5 Runhong Recent Developments
- 4.3 Sun Pharma
- 4.3.1 Sun Pharma Company Information
- 4.3.2 Sun Pharma Business Overview
- 4.3.3 Sun Pharma Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sun Pharma Vinpocetine Product Portfolio
- 4.3.5 Sun Pharma Recent Developments
- 4.4 WZT
- 4.4.1 WZT Company Information
- 4.4.2 WZT Business Overview
- 4.4.3 WZT Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 WZT Vinpocetine Product Portfolio
- 4.4.5 WZT Recent Developments
- 4.5 PUDE
- 4.5.1 PUDE Company Information
- 4.5.2 PUDE Business Overview
- 4.5.3 PUDE Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 PUDE Vinpocetine Product Portfolio
- 4.5.5 PUDE Recent Developments
- 4.6 Welman
- 4.6.1 Welman Company Information
- 4.6.2 Welman Business Overview
- 4.6.3 Welman Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Welman Vinpocetine Product Portfolio
- 4.6.5 Welman Recent Developments
- 4.7 ZhiTong
- 4.7.1 ZhiTong Company Information
- 4.7.2 ZhiTong Business Overview
- 4.7.3 ZhiTong Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ZhiTong Vinpocetine Product Portfolio
- 4.7.5 ZhiTong Recent Developments
- 4.8 Liaoning Zhiying
- 4.8.1 Liaoning Zhiying Company Information
- 4.8.2 Liaoning Zhiying Business Overview
- 4.8.3 Liaoning Zhiying Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Liaoning Zhiying Vinpocetine Product Portfolio
- 4.8.5 Liaoning Zhiying Recent Developments
- 4.9 COVEX
- 4.9.1 COVEX Company Information
- 4.9.2 COVEX Business Overview
- 4.9.3 COVEX Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 COVEX Vinpocetine Product Portfolio
- 4.9.5 COVEX Recent Developments
- 4.10 Northeast Pharma
- 4.10.1 Northeast Pharma Company Information
- 4.10.2 Northeast Pharma Business Overview
- 4.10.3 Northeast Pharma Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Northeast Pharma Vinpocetine Product Portfolio
- 4.10.5 Northeast Pharma Recent Developments
- 4.11 Micro Labs
- 4.11.1 Micro Labs Company Information
- 4.11.2 Micro Labs Business Overview
- 4.11.3 Micro Labs Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Micro Labs Vinpocetine Product Portfolio
- 4.11.5 Micro Labs Recent Developments
5 Global Vinpocetine Market Scenario by Region
- 5.1 Global Vinpocetine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Vinpocetine Sales by Region: 2021-2032
- 5.2.1 Global Vinpocetine Sales by Region: 2021-2026
- 5.2.2 Global Vinpocetine Sales by Region: 2027-2032
- 5.3 Global Vinpocetine Revenue by Region: 2021-2032
- 5.3.1 Global Vinpocetine Revenue by Region: 2021-2026
- 5.3.2 Global Vinpocetine Revenue by Region: 2027-2032
- 5.4 North America Vinpocetine Market Facts & Figures by Country
- 5.4.1 North America Vinpocetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Vinpocetine Sales by Country (2021-2032)
- 5.4.3 North America Vinpocetine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Vinpocetine Market Facts & Figures by Country
- 5.5.1 Europe Vinpocetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Vinpocetine Sales by Country (2021-2032)
- 5.5.3 Europe Vinpocetine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Vinpocetine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Vinpocetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Vinpocetine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Vinpocetine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Vinpocetine Market Facts & Figures by Country
- 5.7.1 South America Vinpocetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Vinpocetine Sales by Country (2021-2032)
- 5.7.3 South America Vinpocetine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Vinpocetine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Vinpocetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Vinpocetine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Vinpocetine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Vinpocetine Sales by Type (2021-2032)
- 6.1.1 Global Vinpocetine Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Vinpocetine Sales Market Share by Type (2021-2032)
- 6.2 Global Vinpocetine Revenue by Type (2021-2032)
- 6.2.1 Global Vinpocetine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Vinpocetine Revenue Market Share by Type (2021-2032)
- 6.3 Global Vinpocetine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Vinpocetine Sales by Application (2021-2032)
- 7.1.1 Global Vinpocetine Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Vinpocetine Sales Market Share by Application (2021-2032)
- 7.2 Global Vinpocetine Revenue by Application (2021-2032)
- 7.2.1 Global Vinpocetine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Vinpocetine Revenue Market Share by Application (2021-2032)
- 7.3 Global Vinpocetine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Vinpocetine Value Chain Analysis
- 8.1.1 Vinpocetine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Vinpocetine Production Mode & Process
- 8.2 Vinpocetine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Vinpocetine Distributors
- 8.2.3 Vinpocetine Customers
9 Global Vinpocetine Analyzing Market Dynamics
- 9.1 Vinpocetine Industry Trends
- 9.2 Vinpocetine Industry Drivers
- 9.3 Vinpocetine Industry Opportunities and Challenges
- 9.4 Vinpocetine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst